Why SK Life Science Labs’ AACR 2026 data could put targeted protein degradation back in the oncology spotlight
What Doximity (NYSE: DOCS) CFO resignation means for governance, capital allocation, and investor confidence
Read More Healthcare Industry News FDA clears Atia Vision’s OmniVu Lens for U.S. clinical trial, signaling a breakthrough in cataract surgery Atia Vision gets FDA green light to begin U.S. trials of its OmniVu™ Lens, aiming to restore full-range vision post-cataract surgery. See how it may redefine care. byPallavi MadhirajuMay 20, 2025